Virulence of three distinct Cryptosporidium parvum isolates for healthy adults

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1275-1281

  Okhuysen, Pablo C ^a   Chappell, Cynthia L ^a   Crabb, Joseph H ^c   Sterling, Charles R ^d   DuPont, Herbert L ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c ImmuCell Corporation   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; DIARRHEA; FECES ANALYSIS; GENOTYPE; HUMAN; INFECTION RATE; NONHUMAN; OOCYST; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTOZOAL INFECTION;

ADULT; ANIMALS; CATTLE; CONFIDENCE INTERVALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENOTYPE; HUMANS; IOWA; PARASITE EGG COUNT; TIME FACTORS; VIRULENCE;

EID: 0033394114     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315033     Document Type: Article

References (46)

1. Goldstein S, Juraneck D, Ravenholt O, et al. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the art water treatment. Ann Intern Med 1996; 124:459-68.
2. Mac Kenzie W, Hoxie N, Proctor M, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331:161-7.
3. Flanigan TP, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 count. Ann Intern Med 1992; 116:840-2.
4. Goodgame RW, Genta RM, White AC, Chappell CL. Intensity of infection in AIDS-associated cryptosporidiosis. J Infect Dis 1993; 167:704-9.
5. Goodgame RW, Kimball K, Ou CN, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995; 108:1075-82.
6. Hashmey R, Smith N, Cron S, Graviss E, Chappell C, White C. Cryptosporidiosis in Houston, Texas. A report of 95 cases, Medicine 1997; 76:118-39.
7. Puzio E, Gomez-Morales M, Barbieri F, La-Rosa G. Cryptosporidium: different behaviour in calves of isolates of human origin. Trans R Soc Trop Med Hyg 1992; 86:636-8.
8. Ditrich O, Kopacek P, Kucerova Z. Antigenic charactrization of human isolates of cryptosporidia. Folia Parasitol 1993; 40:301-5.
9. Mead JR, Humphreys RC, Sammons DW, Sterling CR. Identification of isolate-specific sporozoite proteins of Cryptosporidium parvum by two-dimensional gel electrophoresis. Infect Immun 1990; 58:2071-5.
10. Lumb R, Lanser JA, O'Donoghue PJ. Electrophoretic and immunoblot analysis of Cryptosporidium oocysts. Immunol Cell Biol 1988; 66:369-76.
11. Peng MM, Xiao L, Freeman AR, et al. Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis 1997; 3:567-73.
12. Bonnin A, Fourmaux MN, Dubremetz JF, et al. Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol Lett 1996; 137:207-11.
13. Carraway M, Tzipori S, Widmer G. Identification of genetic heterogeneity in the Cryptosporidium ribosomal repeat. Appl Environ Microbiol 1996; 62:712-6.
14. Morgan UM, O'Brien PA, Thompson RC. The development of diagnostic PCR primers for Cryptosporidium using RAPD-PCR. Mol Biochem Parasitol 1996; 77:103-8.
15. Morgan UM, Constantine CC, Forbes DA, Thompson RC. Differentiation between human and animal isolates of Cryptosporidium parvum using rDNA sequencing and direct PCR analysis. J Parasitol 1997; 83:825-30.
16. Morgan UM, Sargent KD, Deplazes P, et al. Molecular characterization of Cryptosporidium from various hosts. Parasitology 1998; 117:31-7.
17. Patel S, Pedraza-Diaz S, McLauchlin J, Casemore DP, Molecular characterisation of Cryptosporidium parvum from two large suspected waterborne outbreaks. Outbreak Control Team South and West Devon 1995. Incident Management Team and Further Epidemiological and Microbiological Studies Subgroup North Thames 1997 [In Process Citation]. Commun Dis Public Health 1998; 1:231-3.
18. Chappell C, Okhuysen P, Sterling C, Wang C, Jakubowski W, DuPont H, Infectivity of Cryptosparidium parvum in healthy adults with pre-existing anti-C parvum IgG. Am J Trop Med Hyg 1999; 60:157-64.
19. DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidum parvum in healthy volunteers. N Engl J Med 1995; 332:855-9.
20. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 1996; 173:232-6.
21. Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 1998; 66:441-3.
22. Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET. DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 1998; 26:1324-9.
23. Arrowood M, Sterling C. Isolation of Cryptosporidium oocysts and sporozoites using discontinous sucrose and isopycnic percoll gradients. J Parasitol 1987; 73:314-9.
24. Atlas RS, DuPont HL, Overall JE. Computer simulation of alternative sampling strategies to estimate risk of infection from Cryptosporidium. Comput Biol Med 1993; 23:283-94.
25. Valdez LM, Dang H, Okhuysen PC, Chappell CL. Flow cytometric detection of Cryptosporidium oocysts in human stool samples. J Clin Microbiol 1997; 35:2013-7.
26. DuPont H, Cooperstock M, Corrado M, Fekety R, Murray D, General guidelines for the evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Clin Infect Dis 1992; 15 (S1):S228-35.
27. Reed L, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-7.
28. Meinhardt PL, Casemore DP, Miller KB. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiology Rev 1996; 18:118-36.
29. Robertson L, Campbell A, Smith H. Survival of Cryptosporidium parvum oocysts under various environmental pressures. Appl Environ Microbiol 1992; 58:3494-3500.
30. Moss DM, Chappell CL, Okhuysen PC, et al. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens after experimental infection in humans. J Infect Dis 1998; 178:827-33.
31. Moss D, Bennett S, Arrowood M, et al. Kinetic and isotopic analysis of specific immunoglobulins from crew members with cryptosporidiosis on a US coast guard cutter. J Eukaryot Microbiol 1994; 41:52s.
32. Newman R, Zu S, Wuhib T, Lima A, Guerrant R, Sears S. Household epidemiology of Cryptosporidium parvum infection in an urban community in Northeast Brazil. Ann Intern Med 1994; 120:500-5.
33. Widmer G, Tzipori S, Fichtenbaum CJ, Griffiths JK. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J Infect Dis 1998; 178:834-40.
34. Mondragon R, Howe DK, Dubey JP, Sibley LD. Genotypic analysis of Toxoplasma gondii isolates from pigs. J Parasitol 1998; 84:639-41.
35. Howe DK, Honore S, Derouin F, Sibley LD. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997; 35:1411-4.
36. Okhuysen PC, DuPont HL, Sterling CR, Chappell CL. Arginine aminopeptidase, an integral membrane protein of the Cryptosporidium parvum sporozoite. Infect Immun 1994; 62:4667-70.
37. Nesterenko V, Tilley M, Upton S. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios 1995; 83:77-88.
38. Steele M, Kuhls T, Nida K, et al. A Cryptosporidium parvum genomic region encoding hemolytic activity. Infect Immun 1995; 63:3840-45.
39. Kuhls T, Mosier D, Crawford D. Effects of carbohydrates and lectins on cryptosporidial sporozoite penetration of cultured cell monolayers. J Protozool 1991; 38:74S-76S.
40. Thea D, Pereira M, Kotler D, Sterling C, Keush G. Identification and partial purification of a lectin on the surface of the sporozoite of Cryptosporidium parvum. J Parasitol 1992; 78:886-93.
41. Barnes DA, Bonnin A, Huang JX, et al. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol Biochem Parasitol 1998; 96:93-110.
42. Spano F, Putignani L, Guida S, Crisanti A. Cryptosporidium parvum: PCR-RFLP analysis of the TRAP-CI (thrombospondin-related adhesive protein of Cryptosparidum-1) gene discriminates between two alleles differentially associated with parasite isolates of animal and human origin. Exp Parasitol 1998; 90:195-8.
43. Tilley M, Upton S. Both Cp15 and CP25 are left us trails behind gliding sporozoites of Cryptosporidium parvum. FEMS Microbiol Lett 1994; 113:275-8.
44. Guarino A, Canani RB, Pozio E, Terracciano L, Albano F, Mazzeo M, Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum. Gastroenterology 1994; 106:28-34.
45. Guarino A, Canani RB, Casola A, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995; 171:976-83.
46. Fayer R. Effect of sodium hypochlorite exposure on infectivity of Cryptosporidum parvum oocysts for BALB/c mice. Appl Environ Microbiol 1995; 61:844-6.